Depending on the level of evidence provided and the methodology used, this advice is typically conveyed through a Guidance, a Systematic review or an Expert opinion.
As of 2 March 2020, ECDC no longer defines areas of presumed community transmission. Please refer to WHO situation reports for country classification [hyperlink: https://www.who.int/emergencies/diseases/novel-coronavirus-2019/situation-reports/
Find ECDC resources on preparedness and prevention and control measures of COVID-19, such as guidance and technical reports for patient and case management, personal protective equipment, preventive measures.
How is the coronavirus outbreak affecting Europe and Sweden and which counter measures are being taken? ECDC’s Director Andrea Ammon will explain the current rapidly evolving situation and what is being done at the European level. DG Johan Carlson from Folkhälsomyndigheten will explain what is the situation in Sweden.
The ISIRV (International Society for Influenza and other Respiratory Virus Diseases) Epidemiology Group and ECDC are holding an influenza epidemiology meeting at ECDC in Stockholm 16-18 January 2019.
In a two-day meeting organised by ECDC and UNAIDS, representatives of 22 European countries discussed how to improve the delivery of HIV pre-exposure prophylaxis (PrEP) across Europe. The meeting brought together country delegates, PrEP users and community HIV advocates to seek ways to strengthen the provision and monitoring of PrEP.
When people with infectious tuberculosis (TB) cough, sneeze or otherwise exhale droplets, they expose others to Mycobacterium tuberculosis. After a person is exposed, they can be infected with M. tuberculosis without having TB disease and without signs and symptoms. This is called latent TB infection (LTBI).